Symbol="GRTX"
AssetType="Common Stock"
Name="Galera Therapeutics Inc"
Description="Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the transformation of radiation therapy in cancer. The company is headquartered in Malvern, Pennsylvania."
CIK="1563577"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 WEST LIBERTY BLVD #100, MALVERN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="11580500"
EBITDA="-51850000"
PERatio="None"
PEGRatio="None"
BookValue="-3.83"
DividendPerShare="0"
DividendYield="0"
EPS="-2.09"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.496"
ReturnOnEquityTTM="-10.63"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.09"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="2.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="29.39"
EVToRevenue="-"
EVToEBITDA="-0.0899"
Beta="1.727"
num_52WeekHigh="3.59"
num_52WeekLow="0.253"
num_50DayMovingAverage="2.59"
num_200DayMovingAverage="2.282"
SharesOutstanding="42906800"
DividendDate="None"
ExDividendDate="None"
symbol="GRTX"
open="0.30"
high="0.30"
low="0.25"
price="0.27"
volume="6174107.00"
latest_trading_day="2023-08-15"
previous_close="0.30"
change="-0.03"
change_percent="-10.0333%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="1565320"
Change_recent_avg="-0.02"
Delta_recent_avg="0.19"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.8"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="98"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_negative_thumbnail_id_2="165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="624"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
